Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

20.01.2025

6 BMC Cancer
4 Int J Cancer
1 J Cutan Pathol
1 Lancet
1 Mycoses
1 N Engl J Med
8 PLoS One
1 Proc Natl Acad Sci U S A



    BMC Cancer

  1. BECK MH, Brachaczek IA, Gebert P, Blohmer JU, et al
    Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysis.
    BMC Cancer. 2025;25:91.
    >> Share

  2. LIU M, Kilbreath S, Yee J, Beith J, et al
    Motivations and perceptions for physical activity in women living with metastatic breast cancer: a qualitative interview study.
    BMC Cancer. 2025;25:80.
    >> Share

  3. NASERI H, Safaei AA
    Diagnosis and prognosis of melanoma from dermoscopy images using machine learning and deep learning: a systematic literature review.
    BMC Cancer. 2025;25:75.
    >> Share

  4. BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
    Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
    BMC Cancer. 2025;25:72.
    >> Share

  5. CUMMINGS-JOHN C, Bah AJ, Smalle IO, Challe CC, et al
    The patterns of presentation, management and outcomes of breast cancer patients at a tertiary health facility in Sierra Leone.
    BMC Cancer. 2025;25:70.
    >> Share

  6. FENG Y, Song Q, Yan L, Li R, et al
    Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups.
    BMC Cancer. 2025;25:68.
    >> Share


    Int J Cancer

  7. CHEN Y, Salas LA, Marotti JD, Jenkins NP, et al
    Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer.
    Int J Cancer. 2024 Dec 5. doi: 10.1002/ijc.35274.
    >> Share

  8. JIANG C, Freedman RA, Punglia RS, Jemal A, et al
    Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States.
    Int J Cancer. 2024 Nov 13. doi: 10.1002/ijc.35257.
    >> Share

  9. CAO L, Ou D, Qi WX, Xu C, et al
    A randomized trial of early cardiotoxicity in breast cancer patients receiving postoperative IMRT with or without serial cardiac dose constraints.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35245.
    >> Share

  10. HOLDER EX, Bigham Z, Nelson KP, Barnard ME, et al
    Mammographic density and breast cancer risk among Black American women.
    Int J Cancer. 2024 Oct 19. doi: 10.1002/ijc.35223.
    >> Share


    J Cutan Pathol

  11. KO CJ, Odell I, Gehlhausen JR, Leventhal J, et al
    VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis.
    J Cutan Pathol. 2025;52:108-112.
    >> Share


    Lancet

  12. FIORENTINO D, Mangold AR, Werth VP, Christopher-Stine L, et al
    Efficacy, safety, and target engagement of dazukibart, an IFNbeta specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2025;405:137-146.
    >> Share


    Mycoses

  13. ROMAN-MONTES CM, Gonzalez-Lara F, Diaz-Lomeli P, Sanchez AC, et al
    Molecular Identification and Antifungal Susceptibility of Fusarium spp. Clinical Isolates.
    Mycoses. 2025;68:e70012.
    >> Share


    N Engl J Med

  14. GEYER CE JR, Untch M, Huang CS, Mano MS, et al
    Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
    N Engl J Med. 2025;392:249-257.
    >> Share


    PLoS One

  15. MY NTT, My LH, Minh VN, Vinh NTH, et al
    Factors associated with quality of life of chronic spontaneous urticaria patients in a Vietnamese population.
    PLoS One. 2025;20:e0317499.
    >> Share

  16. LI G, Yu Q, Dong F, Wu Z, et al
    A recurrence model for non-puerperal mastitis patients based on machine learning.
    PLoS One. 2025;20:e0315406.
    >> Share

  17. MUSTAFA S, Jaffar A, Rashid M, Akram S, et al
    Deep learning-based skin lesion analysis using hybrid ResUNet++ and modified AlexNet-Random Forest for enhanced segmentation and classification.
    PLoS One. 2025;20:e0315120.
    >> Share

  18. CHAHARLASHKAR Z, Saeedi Honar Y, Abdollahpour-Alitappeh M, Parvizpour S, et al
    Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies.
    PLoS One. 2025;20:e0312754.
    >> Share

  19. BANAR M, Kamyab H, Torkashvand N, Zahraei Salehi T, et al
    A novel broad-spectrum bacteriophage cocktail against methicillin-resistant Staphylococcus aureus: Isolation, characterization, and therapeutic potential in a mastitis mouse model.
    PLoS One. 2025;20:e0316157.
    >> Share

  20. ANOSOVA O, Head A, Collins B, Alexiou A, et al
    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.
    PLoS One. 2025;20:e0313877.
    >> Share

  21. GUPTA AK, Economopoulos V, Wang T, Piguet V, et al
    Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program.
    PLoS One. 2025;20:e0316681.
    >> Share

  22. AYEBENG C, Okyere J, Okantey C, Addo IY, et al
    Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.
    PLoS One. 2025;20:e0316800.
    >> Share


    Proc Natl Acad Sci U S A

  23. CORRALES RM, Vincent J, Crobu L, Neish R, et al
    Tubulin detyrosination shapes Leishmania cytoskeletal architecture and virulence.
    Proc Natl Acad Sci U S A. 2025;122:e2415296122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016